Novartis Bought a Platform. The Lead Drug Just Failed. Now What?
The del-desiran miss raises a question large-cap pharma investors dodge: how much of a share price is pipeline hope, and…
The del-desiran miss raises a question large-cap pharma investors dodge: how much of a share price is pipeline hope, and…
When travel sells off with no company news, crude is hitting demand next.
When yields swing and portfolios reposition, Tradeweb collects a fee on every trade, and August’s data shows how durable that…
A record ¥1 trillion retail bond priced last week. Savers fund Son’s AI bet.
SpaceX is about 34% below its June peak. That is the price discovery Anthropic's bankers are racing to get ahead…
The first pause in six months removes a near-term supply overhang, but the group said nothing about November or December,…
Fiscal Q4 earnings are expected Sept. 24, and Jabil has raised its FY2026 AI revenue outlook to about $13.6B. The…
Tuesday’s earnings cover the priciest Labor Day fuel stretch, and the math works differently than drivers think.
The rollback is done. Sunday's decision sets whether XLE, XOM, and CVX hold gains into Tuesday.
Brazil’s rally is real, but for U.S. investors the currency does as much work as the index.